Introduction and Objective: KCNK17, which encodes TALK-2, is one of the most abundant β-cell K+ channel transcripts. Polymorphisms in KCNK17 are associated with an increased predisposition for developing T2D. Therefore, our objective was to determine the β-cell functions of TALK-2.
Methods: Localization of TALK-2 was investigated with immunofluorescent staining and TALK-2-GFP constructs. TALK-2 function was tested with Ca2+ imaging of inducible TALK-2 cells, adenoviral KCNK17 shRNA mediated knockdown (KD) of dispersed human islets, and β-cell TALK-2 KD pseudoislets. Insulin secretion was performed with pseudoislets.
Results: TALK-2 protein displayed ER localization in β-cells within human pancreatic sections. Additionally, TALK-2-GFP colocalized with an ER-RFP marker and a plasmalemma dye in HEK293 cells. Overexpression of TALK-2 in HEK293 cells accelerated ER Ca2+ release (by 62±13%), reduced ER Ca2+ storage (by 67±12%) and increased basal cytosolic Ca2+ (by 11±0.5%). In human β-cells TALK-2 KD increased ER Ca2+ storage (by 16±5%). Moreover, TALK-2 KD increased Ca2+ influx at 11mM glucose in human β-cells that were dispersed (by 20±6%) and in pseudoislet preps (by 208±64%). Finally, β-cell TALK-2 KD pseudoislets showed reduced insulin secretion at 1mM (by 36±10%).
Conclusion: These data support that ER and plasmalemma localized TALK-2 channels function to reduce β-cell ER Ca2+ stores and limit glucose-induced Ca2+ influx respectively. Furthermore, TALK-2-mediated augmentation of ER Ca2+ leak likely enhanced basal insulin secretion by increasing cytosolic Ca2+. Therefore, polymorphisms in KCNK17 that increase TALK-2 activity or expression would be predicted to diminish β-cell ER Ca2+ stores, impair glucose-stimulated Ca2+ influx, elevate basal insulin secretion, and thus enhance insulin resistance.
J. Dobson: None. P. Dadi: None. A.Y. Nakhe: None. D. Jacobson: None.
Initiative for Maximizing Student Development at Vanderbilt (T32GM139800)Multidisciplinary Training in Molecular Endocrinology(T32DK007563); National Institutes of Health (DK-097392)